Related Experiment Video
Updated: Jun 22, 2026

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
Development of PBPK model of molinate and molinate sulfoxide in rats and humans
1Department of Environmental Toxicology, UC Davis, Davis, CA 95616, USA. arc40@astound.net
Abstract:
Molinate has been widely used as a pre-emergent herbicide in the rice fields of California's Central Valley. In rat studies, the metabolite molinate sulfoxide is suspected of causing testicular toxicity after exposure to molinate. The sulfoxide is generated in the liver and can circulate in the blood, eventually reaching the testis. Man qualitatively produces the same molinate metabolites as the rat. To extrapolate the reproductive risk to man, the present study outlines the development of a preliminary PBPK (physiologically-based pharmacokinetic) model, validation in the rat and extrapolation to man. The preliminary seven-compartment PBPK model for molinate was constructed for the adult, male Sprague-Dawley rat that employed both flow-limited (blood, kidney, liver, rapid-perfused tissues and slowly perfused tissues) and diffusion-limited (fat) rate equations. The systemic circulation connects the various compartments. The simulations predict the molinate blood concentrations of the rat blood and testes compartment favorably with the profiles obtained from 10 and 100mg/kg po or 1.5 and 15mg/kg iv doses. Human physiological parameters were substituted into the oral dosed model and the simulations closely predicted the molinate blood concentration obtained from 5.06mg oral dose. A sensitivity analysis determined for an oral dose that peak blood molinate concentrations were most responsive to the blood flows to kidney and fat compartments while testicular molinate sulfoxide concentrations depended on molinate sulfoxide partition coefficients for the testes compartment and the K(m) for glutathione conjugation of molinate sulfoxide in the liver compartment.
Insights
This study developed a physiologically-based pharmacokinetic (PBPK) model to assess testicular toxicity risk from the herbicide molinate. The model, validated in rats, was extrapolated to humans, predicting molinate concentrations in blood and testes.
Area of Science:
- Environmental toxicology
- Pharmacokinetics
- Reproductive toxicology
Background:
- Molinate is a widely used herbicide in California rice fields.
- Molinate sulfoxide, a metabolite, is suspected of causing testicular toxicity in rats.
- Humans produce similar molinate metabolites as rats.
Purpose of the Study:
- To develop a preliminary physiologically-based pharmacokinetic (PBPK) model for molinate.
- To validate the PBPK model in rats.
- To extrapolate the model to humans for reproductive risk assessment.
Main Methods:
- A seven-compartment PBPK model was constructed for male Sprague-Dawley rats.
- The model incorporated flow-limited and diffusion-limited rate equations.
- Model simulations were compared against experimental molinate concentrations from oral and intravenous doses in rats and a human oral dose.
Main Results:
- The PBPK model accurately predicted molinate blood concentrations in rats across various doses.
- The model successfully predicted human molinate blood concentrations after a 5.06mg oral dose.
- Sensitivity analysis identified key parameters influencing molinate and molinate sulfoxide concentrations.
Conclusions:
- The PBPK model provides a valuable tool for assessing molinate's reproductive risk.
- Extrapolation to humans suggests potential for molinate exposure assessment.
- Key factors influencing testicular exposure to molinate sulfoxide were identified.
More Related Videos
08:28Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
Published on: December 14, 2021
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...